CymitQuimica logo

CAS 1286770-55-5

:

N-[3-[(5R)-3-Amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide

Description:
N-[3-[(5R)-3-Amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide is a chemical compound characterized by its complex structure, which includes a thiadiazine ring, multiple fluorine substituents, and an amide functional group. This compound is notable for its potential pharmacological applications, particularly in the field of medicinal chemistry, where it may exhibit biological activity against specific targets. The presence of the fluorine atoms can enhance lipophilicity and metabolic stability, which are desirable properties in drug design. The thiadiazine moiety contributes to its unique reactivity and interaction with biological systems. Additionally, the compound's stereochemistry, indicated by the (5R) configuration, may influence its biological activity and binding affinity to target proteins. Overall, this substance represents a class of compounds that may be explored for therapeutic uses, although specific biological data and safety profiles would need to be evaluated through further research.
Formula:C17H17F2N5O3S
InChI:InChI=1S/C17H17F2N5O3S/c1-17(9-28(26,27)24(2)16(20)23-17)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)/t17-/m0/s1
InChI key:InChIKey=YHYKUSGACIYRML-KRWDZBQOSA-N
SMILES:C[C@@]1(C2=CC(NC(=O)C3=CC=C(F)C=N3)=CC=C2F)CS(=O)(=O)N(C)C(N)=N1
Synonyms:
  • 2-Pyridinecarboxamide, N-[3-[(5R)-3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-
  • Verubecestat
  • MK 8931
  • N-[3-[(5R)-3-Amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide
Found 7 products.
  • Verubecestat

    CAS:
    Verubecestat
    Formula:C17H17F2N5O3S
    Purity:99.5%
    Molecular weight:409.41

    Ref: 54-BUP12954

    5mg
    89.00€
    10mg
    121.00€
    25mg
    222.00€
    50mg
    315.00€
    100mg
    505.00€
    500mg
    1,139.00€
  • Verubecestat

    CAS:
    Verubecestat (MK-8931) (MK-8931) is an effective and specific β-secretase inhibitor and β-site APP-cleaving enzyme 1 inhibitor or BACE1 protein inhibitor.
    Formula:C17H17F2N5O3S
    Purity:94.64% - 99.55%
    Color and Shape:Solid
    Molecular weight:409.41

    Ref: TM-T7011

    2mg
    38.00€
    5mg
    56.00€
    1mL*10mM (DMSO)
    62.00€
    10mg
    83.00€
    25mg
    144.00€
    50mg
    205.00€
    100mg
    334.00€
    500mg
    782.00€
  • (R)-N-(3-(3-Amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropicolinamide

    CAS:
    (R)-N-(3-(3-Amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropicolinamide
    Formula:C17H17F2N5O3S
    Purity:98%
    Molecular weight:409.41

    Ref: IN-DG689152

    5mg
    95.00€
    10mg
    127.00€
    25mg
    218.00€
  • VERUBECESTAT

    CAS:
    Purity:98%
    Molecular weight:409.4100037

    Ref: 10-F859262

    5mg
    To inquire
    1mg
    49.00€
  • Verubecestat

    Controlled Product
    CAS:

    Applications Verubecestat is used in a β-site amyloid precursor protein cleaving enzyme I inhibitor of treatment of alzheimer’s disease.
    References Scott, J. et al.: J. Med. Chem., 59, 10435 (2016);

    Formula:C17H17F2N5O3S
    Color and Shape:Neat
    Molecular weight:409.41

    Ref: TR-V128850

    5mg
    150.00€
    10mg
    244.00€
    25mg
    373.00€
  • Verubecestat

    CAS:
    Verubecestat is an experimental drug that has been shown to reduce the production of amyloid-beta protein, one of the key proteins in Alzheimer's disease. Verubecestat acts by blocking the activity of beta-secretase 1 (BACE1), which is an enzyme that is involved in the production of amyloid-beta protein. The drug also inhibits acetylcholine release and neuronal death, thereby reducing neuronal dysfunction. Verubecestat has been shown to be well tolerated with no adverse effects seen in clinical trials. It is being studied for use as a symptomatic treatment for patients with mild to moderate Alzheimer's disease. There are few side effects associated with this drug and it does not appear to cause any significant changes in laboratory values or blood counts.
    Formula:C17H17F2N5O3S
    Purity:Min. 95%
    Molecular weight:409.41 g/mol

    Ref: 3D-LBC77055

    10mg
    384.00€
    25mg
    547.00€
    50mg
    713.00€
    100mg
    1,038.00€
    250mg
    1,832.00€
  • Ref: IN-DA000YAT

    100mg
    Discontinued
    1mg
    Discontinued
    5mg
    Discontinued
    25mg
    Discontinued
    Discontinued product